Proline oxidase activates both intrinsic and extrinsic pathways for apoptosis: The role of ROS/superoxides, NFAT and MEK/ERK signaling

Oncogene

Volumn 25, Issue 41, 2006, Pages 5640-5647

  Liu, Y ^a   Borchert, G L ^b   Surazynski, A ^a   Hu, C A ^c   Phang, J M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

^c UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

Author keywords

Apoptosis; ERK; Metabolism; NFAT; Proline oxidase; Superoxide radicals

Indexed keywords

BENZYLOXYCARBONYLISOLEUCYLGLUTAMYLTHREONYLASPARTYL FLUOROMETHYL KETONE; CASPASE 8; CASPASE 8 INHIBITOR; DEATH RECEPTOR; MANGANESE SUPEROXIDE DISMUTASE; MITOGEN ACTIVATED PROTEIN KINASE; PROLINE DEHYDROGENASE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; TETRACYCLINE; TRANSCRIPTION FACTOR NFAT; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DRUG INHIBITION; FLOW CYTOMETRY; GENE CONTROL; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION;

APOPTOSIS; CELL LINE, TUMOR; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; MAP KINASE KINASE KINASES; NFATC TRANSCRIPTION FACTORS; PROLINE OXIDASE; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; SUPEROXIDES;

EID: 33748671329     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209564     Document Type: Article

References (38)

1. Adams E. (1970). Int Rev Connect Tissue Res 5: 1-91.
2. Cai J, Jones DP. (1998). J Biol Chem 273: 11401-11404.
3. Crabtree GR, Olson EN. (2002). Cell 109(Suppl): S67-79.
4. Cross TG, Scheel-Toellner D, Henriquez NV, Deacon E, Salmon M, Lord JM. (2000). Exp Cell Res 256: 34-41.
5. Delwing D, Bavaresco CS, Chiarani F, Wannmacher CM, Wajner M, Dutra-Filho CS et al. (2003). Brain Res 991: 180-186.
6. Donald SP, Sun XY, Hu CA, Yu J, Mei JM, Valle D et al. (2001). Cancer Res 61: 1810-1815.
7. Duque J, Fresno M, Iniguez MA. (2005). J Biol Chem 280: 8686-8693.
8. Dussmann H, Kogel D, Rehm M, Prehn JH. (2003). J Biol Chem 278: 12645-12649.
9. Hagedorn CH, Phang JM. (1983). Arch Biochem Biophys 225: 95-101.
10. Hamilton G, Olszewski U, Ulsperger E, Baumgartner G. (2004). J Clin Oncol 22: 3164.
11. Holmstrom TH, Schmitz I, Soderstrom TS, Poukkula M, Johnson VL, Chow SC et al. (2000). EMBO J 19: 5418-5428.
12. Kelley SK, Ashkenazi A. (2004). Curr Opin Pharmacol 4: 333-339.
13. Latinis KM, Norian LA, Eliason SL, Koretzky GA. (1997). J Biol Chem 272: 31427-31434.
14. Liu Y, Borchert GL, Donald SP, Surazynski A, Hu CA, Weydert CJ et al. (2005). Carcinogenesis 26: 1335-1342.
15. Loo G. (2003). J Nutr Biochem 14: 64-73.
16. Lu KP. (2003). Cancer Cell 4: 175-180.
17. Macias MJ, Wiesner S, Sudol M. (2002). FEBS Lett 513: 30-37.
18. Maxwell SA, Rivera A. (2003). J Biol Chem 278: 9784-9789.
19. McCaffrey PG, Goldfeld AE, Rao A. (1994). J Biol Chem 269: 30445-30450.
20. Nakano K, Vousden KH. (2001). Mol Cell 7: 683-694.
21. Pani G, Colavitti R, Bedogni B, Fusco S, Ferraro D, Borrello S. (2004). Curr Med Chem 11: 1299-1308.
22. Phang JM. (1985). Curr Top Cell Regul 25: 91-132.
23. Phang JM, Downing SJ, Yeh GC, Smith RJ, Williams JA, Hagedorn CH et al. (1982). J Cell Physiol 110: 255-261.
24. Phang JM, Hu C-A, Valle D. (2001). The Metabolic and Molecular Bases of Inherited Disease. Scriver CR, Beaudet AL, Sly WS and Valle D (eds). McGraw Hill: New York, pp 1821-1838.
25. Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B. (1997). Nature 389: 300-305.
26. Rivera A, Maxwell SA. (2005). J Biol Chem 280: 29346-29354.
27. Semenza GL. (2003). Nat Rev Cancer 3: 721-732.
28. Soderstrom TS, Poukkula M, Holmstrom TH, Heiskanen KM, Eriksson JE. (2002). J Immunol 169: 2851-2860.
29. Tran SE, Holmstrom TH, Ahonen M, Kahari VM, Eriksson JE. (2001). J Biol Chem 276: 16484-16490.
30. Wada T, Penninger JM. (2004). Oncogene 23: 2838-2849.
31. Wang Q, Ji Y, Wang X, Evers BM. (2000). Biochem Biophys Res Commun 276: 466-471.
32. Wenzel U, Kuntz S, De Sousa UJ, Daniel H. (2003). Int J Cancer 106: 666-675.
33. Wenzel U, Nickel A, Kuntz S, Daniel H. (2004). Carcinogenesis 25: 703-712.
34. Wilson DJ, Alessandrini A, Budd RC. (1999). Cell Immunol 194: 67-77.
35. Wu GS, Burns TF, McDonald III ER, Jiang W, Meng R, Krantz ID et al. (1997). Nat Genet 17: 141-143.
36. Wu GS, Kim K, el-Deiry WS. (2000). Adv Exp Med Biol 465: 143-151.
37. Yu J, Wang Z, Kinzler KW, Vogelstein B, Zhang L. (2003). Proc Natl Acad Sci USA 100: 1931-1936.
38. Yu J, Zhang L, Hwang PM, Kinzler KW, Vogelstein B. (2001). Mol Cell 7: 673-682.